Karen L. Billeci

Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site

Jenny Boström, Shang‐Fan Yu, David Kan et al. · Science · 2009 · 362 citations

Receptor-selective Mutants of Apoptosis-inducing Ligand 2/Tumor Necrosis Factor-related Apoptosis-inducing Ligand Reveal a Greater Contribution of Death Receptor (DR) 5 than DR4 to Apoptosis Signaling

Robert F. Kelley, Klára Tótpál, Stephanie H. Lindstrom et al. · Journal of Biological Chemistry · 2004 · 280 citations · Full text

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Mark Merchant, Xiaolei Ma, Henry R. Maun et al. · Proceedings of the National Academy of Sciences · 2013 · 239 citations · Full text

Hepsin activates pro‐hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor‐1B (HAI‐1B) and HAI‐2

Daniel Kirchhofer, Mark Peek, Michael T. Lipari et al. · FEBS Letters · 2005 · 158 citations

Hepsin Activity, Active Two-chain Hgf, Tumor Biology +17

Structural and Functional Basis of the Serine Protease-like Hepatocyte Growth Factor β-Chain in Met Binding and Signaling

Daniel Kirchhofer, Xiaoyi Yao, Mark Peek et al. · Journal of Biological Chemistry · 2004 · 86 citations · Full text